Share this
Cooley Elects 28 New Partners for January 1, 2022
November 29, 2021
Cooley Advises Meredith on $3.5 Billion of Debt Financings
February 5, 2018
Valeritas – $53 Million IPO
April 7, 2017
ObsEva – $97 Million IPO
February 16, 2017
Clearside – $36 Million Public Offering
January 3, 2017
Aclaris Therapeutics – $105 Million Follow-On Offering
November 30, 2016
Clearside IPO – $50 Million
June 21, 2016
Senseonics Holdings, Inc. – $49 Million IPO
April 13, 2016
Aclaris Therapeutics – IPO
October 20, 2015
Axovant Completes $362 Million IPO
June 16, 2015
KemPharm Completes its Initial Public Offering
April 28, 2015
OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals
January 14, 2015
Vascular Biogenics Prices its Initial Public Offering
November 5, 2014
Cooley Advises Underwriters on T2 Biosystems IPO
August 22, 2014
Cooley Advises 2U on $119 Million IPO
April 15, 2014
Cooley Advises Underwriters on Amedica IPO
March 4, 2014
Cooley Advises on First US IPO of 2014 for GlycoMimetics
January 23, 2014